PAT-DX1
Vasculitis / Inflammatory Disease
PreclinicalActive
Key Facts
About Patrys
Patrys leverages a reformulated quetiapine IV and a novel deoxymab platform to address unmet needs in delirium and oncology.
View full company profileVasculitis / Inflammatory Disease
Patrys leverages a reformulated quetiapine IV and a novel deoxymab platform to address unmet needs in delirium and oncology.
View full company profile